Abstract:Despite a generally better prognosis than high-grade glioma (HGG), recurrence and malignant progression are the main causes for the poor prognosis and difficulties in the treatment of low-grade glioma (LGG). It is of great importance to learn about the risk factors and underlying mechanisms of LGG recurrence and progression. In this study, the transcriptome characteristics of four groups, namely, normal brain tissue and recurrent LGG (rLGG), normal brain tissue and secondary glioblastoma (sGBM), primary LGG (pLGG) and rLGG, and pLGG and sGBM, were compared using Chinese Glioma Genome Atlas (CGGA) and Genotype-Tissue Expression Project (GTEx) databases. In this study, 296 downregulated and 396 upregulated differentially expressed genes (DEGs) with high consensus were screened out. Univariate Cox regression analysis of data from The Cancer Genome Atlas (TCGA) yielded 86 prognostically relevant DEGs; a prognostic prediction model based on five key genes (HOXA1, KIF18A, FAM133A, HGF, and MN1) was established using the least absolute shrinkage and selection operator (LASSO) regression dimensionality reduction and multivariate Cox regression analysis. LGG was divided into high- and low-risk groups using this prediction model. Gene Set Enrichment Analysis (GSEA) revealed that signaling pathway differences in the high- and low-risk groups were mainly seen in tumor immune regulation and DNA damage-related cell cycle checkpoints. Furthermore, the infiltration of immune cells in the high- and low-risk groups was analyzed, which indicated a stronger infiltration of immune cells in the high-risk group than that in the low-risk group, suggesting that an immune microenvironment more conducive to tumor growth emerged due to the interaction between tumor and immune cells. The tumor mutational burden and tumor methylation burden in the high- and low-risk groups were also analyzed, which indicated higher gene mutation burden and lower DNA methylation level in the high-risk group, suggesting that with the accumulation of genomic mutations and epigenetic changes, tumor cells continued to evolve and led to the progression of LGG to HGG. Finally, the value of potential therapeutic targets for the five key genes was analyzed, and findings demonstrated that KIF18A was the gene most likely to be a potential therapeutic target. In conclusion, the prediction model based on these five key genes can better identify the high- and low-risk groups of LGG and lay a solid foundation for evaluating the risk of LGG recurrence and malignant progression.

DSN1 may predict poor prognosis of lower-grade glioma patients and be a potential target for immunotherapy

DNAJC10 Correlates with Tumor Immune Characteristics and Predicts the Prognosis of Glioma Patients

DNAJC10 correlates with tumor immune characteristics and predicts the prognosis of glioma

DNA Methylation-Regulated SNX20 Overexpression Correlates with Poor Prognosis, Immune Cell Infiltration, and Low-Grade Glioma Progression

CLSPN is a potential biomarker associated with poor prognosis in low-grade gliomas based on a multi-database analysis

In Silico Analysis Identifies Upregulated Lncrna DLGAP1-AS1 Which is Correlated to Poor Prognosis and Promotes Cell Proliferation in Glioblastoma

Identification of DNA methylation-regulated WEE1 with potential implications in prognosis and immunotherapy for low-grade glioma

DZIP1 Expression As a Prognostic Marker in Gastric Cancer: A Bioinformatics-Based Analysis

Dysregulation of LINC00324 promotes poor prognosis in patients with glioma

The Prognostic Value of DAPK1 Hypermethylation in Gliomas: A Site-Specific Analysis.

DNA Methylation-Driven Genes for Developing Survival Nomogram for Low-Grade Glioma

New biomarker: the gene HLA-DRA associated with low-grade glioma prognosis

Identification of a Glycolysis-Related LncRNA Signature to Predict Survival in Diffuse Glioma Patients

Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy

Identification of disulfidptosis-related genes and immune infiltration in lower-grade glioma

Upregulation of the Long Non-Coding RNA SNHG1 Predicts Poor Prognosis, Promotes Cell Proliferation and Invasion, and Reduces Apoptosis in Glioma.

A Signature of Nine Lncrna Methylated Genes Predicts Survival in Patients with Glioma

The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma

Identification of Methylation Immune Subtypes and Establishment of a Prognostic Signature for Gliomas Using Immune-Related Genes

Integrative Analysis of DNA Methylation and Gene Expression Identify a Three-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas.

A Novel DNA Damage and Repair-Related Gene Signature to Improve Predictive Capacity of Overall Survival for Patients with Gliomas